Overview / Abstract: |
Target Audience This activity is intended for all surgeons and other health care professionals who are involved in the treatment of patients with melanoma. Recent clinical trials suggest new options for neoadjuvant and adjuvant treatments for advanced melanoma. Surgical oncologists need to become familiar with these data to provide optimal treatment to their patients. This webinar is based on the SSO 2019 session. Upon completion of this activity, participants should be able to: Summarize the mechanisms of action and toxicities of novel immunotherapeutic agents for metastatic melanoma |
Expiration |
Jun 18, 2020 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
Format |
Online |
Credits / Hours |
1.0 |
Accreditation |
ACCME, ABS |
Presenters / Authors / Faculty |
Genvieve Boland, MD, PhD (Speaker) Weill Cornelll Medicine Cedars-Sinai Medical Center The Angeles Clinic and Research Institute |
Activity Specialities / Related Topics |
Dermatology, Oncology / Cancer / Radiation Therapy, Surgery |
Sponsors / Supporters / Grant Providers |
Merck, Amgen and Bristol-Myers-Squibb. |
Keywords / Search Terms |
Relias LLC melanoma, cancer, skin Free CE CME |